31 related articles for article (PubMed ID: 8648606)
1. 2-hydroxy-1,4-naphthoquinones with 3-alkyldiarylether groups: synthesis and
Berg A; Swartchick CB; Forrest N; Chavarria M; Deem MC; Sillin AN; Li Y; Riscoe TM; Nilsen A; Riscoe MK; Wood WJ
Future Med Chem; 2022 Nov; 14(22):1611-1620. PubMed ID: 36349868
[TBL] [Abstract][Full Text] [Related]
2. Structure-based evolution of subtype-selective neurotensin receptor ligands.
Schaab C; Kling RC; Einsiedel J; Hübner H; Clark T; Seebach D; Gmeiner P
ChemistryOpen; 2014 Oct; 3(5):206-18. PubMed ID: 25478316
[TBL] [Abstract][Full Text] [Related]
3. The Concise Guide to PHARMACOLOGY 2013/14: G protein-coupled receptors.
Alexander SP; Benson HE; Faccenda E; Pawson AJ; Sharman JL; Spedding M; Peters JA; Harmar AJ;
Br J Pharmacol; 2013 Dec; 170(8):1459-581. PubMed ID: 24517644
[TBL] [Abstract][Full Text] [Related]
4. Current and future applications of GnRH, kisspeptin and neurokinin B analogues.
Millar RP; Newton CL
Nat Rev Endocrinol; 2013 Aug; 9(8):451-66. PubMed ID: 23817290
[TBL] [Abstract][Full Text] [Related]
5. In-cell NMR spectroscopy.
Maldonado AY; Burz DS; Shekhtman A
Prog Nucl Magn Reson Spectrosc; 2011 Oct; 59(3):197-212. PubMed ID: 21920217
[No Abstract] [Full Text] [Related]
6. Screening of small molecule interactor library by using in-cell NMR spectroscopy (SMILI-NMR).
Xie J; Thapa R; Reverdatto S; Burz DS; Shekhtman A
J Med Chem; 2009 Jun; 52(11):3516-22. PubMed ID: 19422228
[TBL] [Abstract][Full Text] [Related]
7. Extended peptoids: a new class of oligomers based on aromatic building blocks.
Combs DJ; Lokey RS
Tetrahedron Lett; 2007 Apr; 48(15):2679-2682. PubMed ID: 18398447
[TBL] [Abstract][Full Text] [Related]
8. Novel NK(3) receptor antagonists for the treatment of schizophrenia and other CNS indications.
Simonsen KB; Juhl K; Steiniger-Brach B; Nielsen SM
Curr Opin Drug Discov Devel; 2010 Jul; 13(4):379-88. PubMed ID: 20597024
[TBL] [Abstract][Full Text] [Related]
9. Osanetant Sanofi-Synthélabo.
Kamali F
Curr Opin Investig Drugs; 2001 Jul; 2(7):950-6. PubMed ID: 11757797
[TBL] [Abstract][Full Text] [Related]
10. Use of a dipeptide chemical library in the development of non-peptide tachykinin NK3 receptor selective antagonists.
Boden P; Eden JM; Hodgson J; Horwell DC; Hughes J; McKnight AT; Lewthwaite RA; Pritchard MC; Raphy J; Meecham K; Ratcliffe GS; Suman-Chauhan N; Woodruff GN
J Med Chem; 1996 Apr; 39(8):1664-75. PubMed ID: 8648606
[TBL] [Abstract][Full Text] [Related]
11. Activation of the cloned human NK3 receptor in Chinese Hamster Ovary cells characterized by the cellular acidification response using the Cytosensor microphysiometer.
Jordan RE; Smart D; Grimson P; Suman-Chauhan N; McKnight AT
Br J Pharmacol; 1998 Oct; 125(4):761-6. PubMed ID: 9831912
[TBL] [Abstract][Full Text] [Related]
12. Discovery of a novel class of selective non-peptide antagonists for the human neurokinin-3 receptor. 2. Identification of (S)-N-(1-phenylpropyl)-3-hydroxy-2-phenylquinoline-4-carboxamide (SB 223412).
Giardina GA; Raveglia LF; Grugni M; Sarau HM; Farina C; Medhurst AD; Graziani D; Schmidt DB; Rigolio R; Luttmann M; Cavagnera S; Foley JJ; Vecchietti V; Hay DW
J Med Chem; 1999 Mar; 42(6):1053-65. PubMed ID: 10090788
[TBL] [Abstract][Full Text] [Related]
13. MEN 11420 (Nepadutant), a novel glycosylated bicyclic peptide tachykinin NK2 receptor antagonist.
Catalioto RM; Criscuoli M; Cucchi P; Giachetti A; Gianotti D; Giuliani S; Lecci A; Lippi A; Patacchini R; Quartara L; Renzetti AR; Tramontana M; Arcamone F; Maggi CA
Br J Pharmacol; 1998 Jan; 123(1):81-91. PubMed ID: 9484857
[TBL] [Abstract][Full Text] [Related]
14. Senktide-induced gerbil foot tapping behaviour is blocked by selective tachykinin NK1 and NK3 receptor antagonists.
Sundqvist M; Kristensson E; Adolfsson R; Leffler A; Ahlstedt I; Engberg S; Drmota T; Sigfridsson K; Jussila R; de Verdier J; Novén A; Johansson A; Påhlman I; von Mentzer B; Lindström E
Eur J Pharmacol; 2007 Dec; 577(1-3):78-86. PubMed ID: 17920583
[TBL] [Abstract][Full Text] [Related]
15. MEN15596, a novel nonpeptide tachykinin NK2 receptor antagonist.
Cialdai C; Tramontana M; Patacchini R; Lecci A; Catalani C; Catalioto RM; Meini S; Valenti C; Altamura M; Giuliani S; Maggi CA
Eur J Pharmacol; 2006 Nov; 549(1-3):140-8. PubMed ID: 16979621
[TBL] [Abstract][Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
